Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: Comparison with non-small-cell lung cancer

Lung Cancer

Volumn 77, Issue 1, 2012, Pages 77-82

  Takeda, Atsuya ^a   Kunieda, Etsuo ^b   Sanuki, Naoko ^a   Aoki, Yousuke ^a   Oku, Yohei ^a   Handa, Hiroshi ^a,c  

^a OFUNA CHUO HOSPITAL   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Non small cell lung cancer; Solitary pulmonary nodule (SPN); Stereotactic body radiotherapy (SBRT)

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CAUSE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALE; METASTASIS FREE SURVIVAL; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; STEREOTACTIC BODY RADIATION THERAPY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOSURGERY; RETROSPECTIVE STUDIES; SOLITARY PULMONARY NODULE; TREATMENT OUTCOME;

EID: 84861749310     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.01.006     Document Type: Article

References (40)

1. Gould M.K., Fletcher J., Iannettoni M.D., Lynch W.R., Midthun D.E., Naidich D.P., et al. Evaluation of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132:108S-130S.
2. Edey A.J., Hansell D.M. Incidentally detected small pulmonary nodules on CT. Clin Radiol 2009, 64:872-884.
3. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365:395-409. [Epub 2011 Jun 29].
4. Rivera M.P., Mehta A.C. Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132:131S-148S.
5. Zarbo R.J., Fenoglio-Preiser C.M. Interinstitutional database for comparison of performance in lung fine-needle aspiration cytology. A College of American Pathologists Q-Probe Study of 5264 cases with histologic correlation. Arch Pathol Lab Med 1992, 116:463-470.
6. Chi A., Liao Z., Nguyen N.P., Xu J., Stea B., Komaki R. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol 2010, 94:1-11.
7. Takeda A., Kunieda E., Shigematsu N., Hossain D.M., Kawase T., Ohashi T., et al. Small lung tumors: long-scan-time CT for planning of hypofractionated stereotactic radiation therapy-initial findings. Radiology 2005, 237:295-300.
8. Takeda A., Kunieda E., Sanuki N., Ohashi T., Oku Y., Sudo Y., et al. Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapy. Int J Radiat Oncol Biol Phys 2009, 74:363-369.
9. Takeda A., Kunieda E., Takeda T., Tanaka M., Sanuki N., Fujii H., et al. Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 2008, 70:1057-1065.
10. Wahidi M.M., Govert J.A., Goudar R.K., Gould M.K., McCrory D.C. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132:94S-107S.
11. Siegelman S.S., Khouri N.F., Leo F.P., Fishman E.K., Braverman R.M., Zerhouni E.A. Solitary pulmonary nodules: CT assessment. Radiology 1986, 160:307-312.
12. Tozaki M., Ichiba N., Fukuda K. Dynamic magnetic resonance imaging of solitary pulmonary nodules: utility of kinetic patterns in differential diagnosis. J Comput Assist Tomogr 2005, 29:13-19.
13. Swensen S.J., Silverstein M.D., Ilstrup D.M., Schleck C.D., Edell E.S. The probability of malignancy in solitary pulmonary nodules Application to small radiologically indeterminate nodules. Arch Intern Med 1997, 157:849-855.
14. Zwirewich C.V., Vedal S., Miller R.R., Muller N.L. Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation. Radiology 1991, 179:469-476.
15. Kishi K., Homma S., Kurosaki A., Motoi N., Kohno T., Nakata K., et al. Small lung tumors with the size of 1cm or less in diameter: clinical, radiological, and histopathological characteristics. Lung Cancer 2004, 44:43-51.
16. Takashima S., Sone S., Li F., Maruyama Y., Hasegawa M., Kadoya M. Indeterminate solitary pulmonary nodules revealed at population-based CT screening of the lung: using first follow-up diagnostic CT to differentiate benign and malignant lesions. AJR Am J Roentgenol 2003, 180:1255-1263.
17. Li F., Sone S., Abe H., Macmahon H., Doi K. Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings. Radiology 2004, 233:793-798.
18. Sato S., Koike T., Yamato Y., Yoshiya K., Motono N., Takeshige M., et al. Diagnostic yield of preoperative computed tomography imaging and the importance of a clinical decision for lung cancer surgery. Gen Thorac Cardiovasc Surg 2010, 58:461-466.
19. Gould M.K., Maclean C.C., Kuschner W.G., Rydzak C.E., Owens D.K. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001, 285:914-924.
20. Khalaf M., Abdel-Nabi H., Baker J., Shao Y., Lamonica D., Gona J. Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules. J Hematol Oncol 2008, 1:13.
21. Dewan N.A., Shehan C.J., Reeb S.D., Gobar L.S., Scott W.J., Ryschon K. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan. Chest 1997, 112:416-422.
22. Kim B.T., Kim Y., Lee K.S., Yoon S.B., Cheon E.M., Kwon O.J., et al. Localized form of bronchioloalveolar carcinoma: FDG PET findings. AJR Am J Roentgenol 1998, 170:935-939.
23. Gurney J.W. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory. Radiology 1993, 186:405-413.
24. Herder G.J., van Tinteren H., Golding R.P., Kostense P.J., Comans E.F., Smit E.F., et al. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest 2005, 128:2490-2496.
25. Swensen S.J., Silverstein M.D., Edell E.S., Trastek V.F., Aughenbaugh G.L., Ilstrup D.M., et al. Solitary pulmonary nodules: clinical prediction model versus physicians. Mayo Clin Proc 1999, 74:319-329.
26. Murai T., Shibamoto Y., Baba F., Hashizume C., Mori Y., Ayakawa S., et al. Progression of non-small-cell lung cancer during the interval before stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2012, 82:463-467.
27. Detterbeck F.C., Gibson C.J. Turning gray: the natural history of lung cancer over time. J Thorac Oncol 2008, 3:781-792.
28. Qiao X., Tullgren O., Lax I., Sirzen F., Lewensohn R. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 2003, 41:1-11.
29. Videtic G.M., Stephans K.L. The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient?. Curr Oncol Rep 2010, 12:235-241.
30. Onishi H., Shirato H., Nagata Y., Hiraoka M., Fujino M., Gomi K., et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007, 2:S94-S100.
31. Timmerman R., Paulus R., Galvin J., Michalski J., Straube W., Bradley J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303:1070-1076.
32. Verstegen N.E., Lagerwaard F.J., Haasbeek C.J., Slotman B.J., Senan S. Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease. Radiother Oncol 2011, 101:250-254.
33. Stephans K.L., Djemil T., Reddy C.A., Gajdos S.M., Kolar M., Mason D., et al. A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience. J Thorac Oncol 2009, 4:976-982.
34. Inoue T., Shimizu S., Onimaru R., Takeda A., Onishi H., Nagata Y., et al. Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination. Int J Radiat Oncol Biol Phys 2009, 75:683-687.
35. Hage R., Seldenrijk K., de Bruin P., van Swieten H., van den Bosch J. Pulmonary large-cell neuroendocrine carcinoma (LCNEC). Eur J Cardiothorac Surg 2003, 23:457-460.
36. Quoix E., Fraser R., Wolkove N., Finkelstein H., Kreisman H. Small cell lung cancer presenting as a solitary pulmonary nodule. Cancer 1990, 66:577-582.
37. Higgins G.A., Shields T.W., Keehn R.J. The solitary pulmonary nodule. Ten-year follow-up of veterans administration-armed forces cooperative study. Arch Surg 1975, 110:570-575.
38. Kreisman H., Wolkove N., Quoix E. Small cell lung cancer presenting as a solitary pulmonary nodule. Chest 1992, 101:225-231.
39. Ciombor K.K., Rocha Lima C.M. Management of small cell lung cancer. Curr Treat Options Oncol 2006, 7:59-68.
40. Davies B., Ghosh S., Hopkinson D., Vaughan R., Rocco G. Solitary pulmonary nodules: pathological outcome of 150 consecutively resected lesions. Interact Cardiovasc Thorac Surg 2005, 4:18-20.